Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Curr Pharm Biotechnol ; 22(3): 367-379, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-31696816

RESUMEN

BACKGROUND: Oleaster or Elaeagnus angustifolia is a deciduous plant from Elaegnacea family and is well-known for its remedial applications. OBJECTIVE: This paper presents a comprehensive review of the potential application of Oleaster's flour incorporated in some food products. Emphasis is given to the physicochemical, biochemical, and functional properties of Oleaster's flour. METHODS: A comprehensive search was carried out to find publications on Oleaster's flour and its application as a prebiotic. The results of the related studies were extracted and summarized in this paper. RESULTS: Oleaster's flour as a prebiotic ingredient enhances antioxidants, polyphenols, fiber, flavonoids, Sterols, carbohydrates, and protein content of food products. CONCLUSION: Further advanced investigations on Oleaster and its functional ingredients revealed that these are efficacious and can be applied as a substitute source in pharmacological industries for medical applications.


Asunto(s)
Elaeagnaceae , Etnobotánica/métodos , Harina/análisis , Extractos Vegetales/análisis , Prebióticos/análisis , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/análisis , Antiinflamatorios/química , Antioxidantes/administración & dosificación , Antioxidantes/análisis , Antioxidantes/química , Cardiotónicos/administración & dosificación , Cardiotónicos/análisis , Cardiotónicos/química , Elaeagnaceae/química , Flavonoides/administración & dosificación , Flavonoides/análisis , Flavonoides/química , Humanos , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Polifenoles/administración & dosificación , Polifenoles/análisis , Polifenoles/química , Prebióticos/administración & dosificación
2.
Curr Pharm Biotechnol ; 21(11): 1042-1051, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32297578

RESUMEN

BACKGROUND: Probiotics can be used for the treatment of viral gastroenteritis. OBJECTIVE: This systematic review is to evaluate the evidence regarding the effect of probiotics on human cases of viral gastroenteritis. METHODS: The objective of this review is to evaluate the effectiveness of probiotics against placebo or standard treatment for viral gastroenteritis. A comprehensive search of Cochrane Library, EMBASE, MEDLINE via PubMed and Ovid databases, and unpublished studies (till 27 January 2018) was conducted followed by a process of study selection and critical appraisal by two independent reviewers. Randomized controlled trials assessing probiotic administration in human subjects infected with any species of gastroenteritis viruses were considered for inclusion. Only studies with a confirmed viral cause of infection were included. This study was developed using the JBI methodology for systematic reviews, which is in accordance with the PRISMA guideline. Meta-analysis was conducted where feasible. Data were pooled using the inverse variance method with random effects models and expressed as Mean Differences (MDs) with 95% Confidence Intervals (CIs). Heterogeneity was assessed by Cochran Q statistic and quantified by the I2 statistic. We included 17 RCTs, containing 3,082 patients. RESULTS: Probiotics can improve symptoms of viral gastroenteritis, including the duration of diarrhea (mean difference 0.7 days, 95% CI 0.31 to 1.09 days, n = 740, ten trials) and duration of hospitalization (mean difference 0.76 days, 95% CI 0.61 to 0.92 days, n = 329, four trials). CONCLUSION: The results of this review show that the administration of probiotics in patients with viral gastroenteritis should be considered.


Asunto(s)
Diarrea/tratamiento farmacológico , Gastroenteritis/tratamiento farmacológico , Probióticos/uso terapéutico , Suplementos Dietéticos , Gastroenteritis/virología , Humanos , Ensayos Clínicos Controlados Aleatorios como Asunto , Infecciones por Rotavirus/tratamiento farmacológico , Infecciones por Rotavirus/virología , Resultado del Tratamiento
3.
Curr Pharm Biotechnol ; 20(11): 985-990, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31322066

RESUMEN

BACKGROUND: Kombucha beverage is considered as a dietary supplement and drinking it strengthens the body's immune system which prevents diseases. OBJECTIVE: The purpose of this study was to determine the amount of glucuronic acid and antibacterial activity of Kombucha black tea drink during its production at different storage temperature. METHODS: The extent of glucuronic acid at temperatures of 20°C and 30°C was explored by the use of the HPLC system for 21 days. To analyse the antibacterial property, the influence of Kombucha black tea supernatant on the growth of Salmonella typhimurium, Staphylococcus aureus, and Lactobacillus rhamnosus bacteria was examined via the two procedures of the disc and agar well diffusion. RESULTS: The production of glucuronic acid underwent a variation at 20°C from 17.0 mg/L on day 1 to roughly 27.2 mg/L on day 21, and the difference was significant. Furthermore, the quantity of this acid at 30°C increased from 42.2 mg/L on day 1 to 48.0 mg/L on day 21. The amount of glucuronic acid produced at 30°C was significantly greater than that at 20°C (p<0.05). This study indicated that the Kombucha black tea has antibacterial activity against Salmonella typhimurium and Staphylococcus aureus, but not against Lactobacillus rhamnosus. However, there are no statistical differences in antibacterial activity of Kombucha between incubation at 20oC and 30oC (P>0.05). CONCLUSION: This study offers a perspective on glucuronic acid production (especially in 30°C rather than 20°C) and antibacterial activity of Kombucha black tea beverage.


Asunto(s)
Antibacterianos/farmacología , Ácido Glucurónico/farmacología , Té de Kombucha , Antibacterianos/biosíntesis , Fermentación , Ácido Glucurónico/biosíntesis , Concentración de Iones de Hidrógeno , Lacticaseibacillus rhamnosus/efectos de los fármacos , Salmonella typhimurium/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Temperatura
4.
Lasers Med Sci ; 33(3): 603-607, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29368069

RESUMEN

Skin graft is a standard therapeutic technique in patients with deep ulcers, but managing donor site after grafting is very important. Although several modern dressings are available to enhance the comfort of donor site, using techniques that accelerate wound healing may enhance patient satisfaction. Low-level laser therapy (LLLT) has been used in several medical fields, including healing of diabetic, surgical, and pressure ulcers, but there is not any report of using this method for healing of donor site in burn patients. The protocols and informed consent were reviewed according to Medical Ethics Board of Shahid Beheshti University of Medical Sciences (IR.SBMU.REC.1394.363) and Iranian Registry of Clinical Trials (IRCT2016020226069N2). Eighteen donor sites in 11 patients with grade 3 burn ulcer were selected. Donor areas were divided into 2 parts, for laser irradiation and control randomly. Laser area was irradiated by a red, 655-nm laser light, 150 mW, 2 J/cm2, on days 0 (immediately after surgery), 3, 5, and 7. Dressing and other therapeutic care for both sites were the same. The patients and the person who analyzed the results were blinded. The size of donor site reduced in both groups during the 7-day study period (P < 0.01) and this reduction was significantly greater in the laser group (P = 0.01). In the present study, for the first time, we evaluate the effects of LLLT on the healing process of donor site in burn patients. The results showed that local irradiation of red laser accelerates wound healing process significantly.


Asunto(s)
Quemaduras/radioterapia , Quemaduras/cirugía , Terapia por Luz de Baja Intensidad/métodos , Trasplante de Piel , Úlcera/radioterapia , Úlcera/cirugía , Cicatrización de Heridas/efectos de la radiación , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Irán , Masculino , Donantes de Tejidos
5.
Lasers Med Sci ; 31(3): 497-502, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26868033

RESUMEN

Significant populations in burn centers are diabetic burn patients. Healing process in these patients is more difficult due to diabetes complications. The gold standard treatment for patients with grade 3 burn ulcer is split-thickness skin grafting (STSG), but in the diabetic patients, the rate of graft failure and amputation is high due to impaired tissue perfusion. The technique of low level laser therapy (LLLT) improves tissue perfusion and fibroblast proliferation, increases collagen synthesis, and accelerates wound healing. The purpose of this case report is introducing a new therapeutic method for accelerating healing with better prognosis in these patients. The protocols and informed consent were reviewed according to the Medical Ethics, Board of Shahid Beheshti Medical Sciences (IR.SBMU.RAM.REC.13940.363). Diabetic type 2 patients with 13 grade 3 burn ulcers, candidate for amputation, were enrolled in the study. We used a 650-nm red laser light, 2 J/Cm for the bed of the ulcer and an 810-nm infrared laser light 6 J/Cm(2) for the margins along with intravenous laser therapy with a 660-nm red light, before and after STSG for treating grade 3 burn ulcers in 13 diabetic ulcers. The results of this study showed complete healing in the last 8 weeks for all patients who were candidates for amputation. In this case series, we present 13 cases of diabetic ulcer with type 3 burn wound, candidate for amputation, who healed completely using LLLT and STSG. This is the first time that these two techniques are combined for treatment of burn ulcer in diabetic patients. Using LLLT with STSG might be a promising treatment for burn victims especially diabetic patients.


Asunto(s)
Quemaduras/radioterapia , Diabetes Mellitus Tipo 2/complicaciones , Úlcera de la Pierna/radioterapia , Terapia por Luz de Baja Intensidad , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Trasplante de Piel , Cicatrización de Heridas/efectos de la radiación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA